GlassScriptPhysician profile
Laura Crowley
NPI 1588128946
$5,718.17
in general payments reported to CMS, 2019-2025
36 companies · $1,732 in 2025
The $1,732 reported for 2025 was more than what 94% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $453 · 2022: $524 · 2023: $1,489 · 2024: $1,520 · 2025: $1,732.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,641 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,640.83 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $721.46 | 2021-2025 | |
| United Therapeutics Corporation | $495.61 | 2023-2025 | Tyvaso, Tyvaso, Orenitram |
| Pfizer INC. | $480.60 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $424.32 | 2021-2025 | Farxiga, Brilinta, Wainua |
| Boehringer Ingelheim Pharmaceuticals, INC. | $415.70 | 2021-2025 | Jardiance |
| Abbott Laboratories | $335.36 | 2023-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems, Amplatzer Amulet |
| Boston Scientific Corporation | $291.96 | 2021-2025 | Watchman Flx, Watchman Access System, Bodyguardian |
| Merck Sharp & Dohme LLC | $255.83 | 2023-2025 | Verquvo, Winrevair |
| Bayer Healthcare Pharmaceuticals INC. | $188.61 | 2024-2025 | |
| Lexicon Pharmaceuticals, INC. | $186.03 | 2023-2024 | Inpefa |
| Janssen Pharmaceuticals, INC | $158.70 | 2021-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $154.78 | 2021-2024 | Lifevest |
| Scpharmaceuticals INC. | $142.14 | 2023-2025 | |
| E.R. Squibb & Sons, L.L.C. | $136.42 | 2021-2025 | Eliquis, Camzyos |
| Amgen INC. | $132.67 | 2022-2025 | Repatha, Repatha |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $125.93 | 2023-2025 | Amvuttra |
| Actelion Pharmaceuticals US, INC. | $124.25 | 2023-2025 | Uptravi, Opsumit, Opsynvi |
| Novo Nordisk INC | $106.83 | 2023-2025 | Ozempic, Wegovy |
| Kiniksa Pharmaceuticals International, Plc | $103.05 | 2024 | Arcalyst |
| Kestra Medical Technology Services, INC. | $97.03 | 2025 | Assure Wcd |
| Heartflow, INC. | $87.55 | 2025 | |
| Bridgebio Pharma, INC. | $83.82 | 2025 | Attruby |
| Philips North America LLC | $83.66 | 2022-2023 | |
| Regeneron Healthcare Solutions, INC. | $62.62 | 2024 | Evkeeza, Dupixent |
| Sanofi-Aventis U.S. LLC | $47.94 | 2023-2024 | |
| Elutia, INC. | $45.02 | 2023-2024 | Ecm Patch,Pouch |
| Cardiva Medical, INC. | $40.91 | 2022 | |
| Lilly USA, LLC | $32.87 | 2025 | Mounjaro, Zepbound |
| Edwards Lifesciences Corporation | $29.50 | 2021 | |
| Cvrx, INC. | $26.01 | 2024 | Barostim Neo System |
| Kiniksa Pharmaceuticals, LTD. | $19.44 | 2023 | Arcalyst |
| Chiesi USA, INC. | $18.28 | 2025 | Juxtapid |
| Inari Medical, INC. | $18.02 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Daiichi Sankyo INC. | $16.57 | 2025 | Injectafer |
| Amarin Pharma, INC. | $15.72 | 2022 | |
| Alexion Pharmaceuticals, INC. | $12.96 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Crowley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.